Advertisement
Screener

QIAGEN N.V. (QGEN) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

QIAGEN N.V. Operating Cash Flow

QIAGEN N.V. (QGEN) reported Operating Cash Flow of $654.33 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-20.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-03-20

Period endNet Cash Provided by (Used in) Operating Activities 12 month
2025-12-31$654.33M
20-F · filed 2026-03-20
2024-12-31$673.55M
20-F · filed 2026-03-20
2023-12-31$459.45M
20-F · filed 2026-03-20
2022-12-31$715.26M
20-F · filed 2025-03-31
2021-12-31$639.00M
20-F · filed 2024-03-11
2020-12-31$457.81M
20-F · filed 2023-03-13
2019-12-31$330.84M
20-F · filed 2022-03-14
2018-12-31$359.50M
20-F · filed 2021-03-05
2017-12-31$286.78M
20-F · filed 2020-03-02
2016-12-31$341.60M
20-F · filed 2019-03-06
2015-12-31$317.50M
20-F · filed 2018-03-06
2014-12-31$287.96M
20-F · filed 2017-03-06
2013-12-31$258.96M
20-F · filed 2016-02-29
2012-12-31$244.88M
20-F · filed 2015-03-02
2011-12-31$244.78M
20-F · filed 2014-03-03
2010-12-31$250.75M
20-F · filed 2013-03-04
2009-12-31$217.00M
20-F · filed 2012-03-27
2008-12-31$173.00M
20-F · filed 2011-03-21